Marseille to Open First Supervised Injection Site in France

A Step Forward in Harm Reduction

Marseille, France, is set to open its first supervised injection site (SIS) in 2023, following the approval of the French government. The site will be located in the city's northern district, an area with a high concentration of drug use and overdose deaths. The SIS will provide a safe and supervised environment for people to inject drugs, with access to medical staff and social services.

Benefits of Supervised Injection Sites

• Reduce overdose deaths: SISs have been shown to reduce overdose deaths by up to 50%.
• Improve health outcomes: SISs provide access to medical care, including wound care, HIV testing, and overdose prevention training.
• Increase access to addiction treatment: SISs can help people overcome addiction by providing referrals to treatment programs and support groups.

Opposition and Concerns

Despite the potential benefits, SISs have faced opposition from some residents and elected officials. Concerns include increased drug use and crime in the surrounding area. However, research has shown that SISs do not lead to increased drug use or crime. In fact, they can help to reduce crime by bringing drug use out of public spaces and into a controlled environment.

Harm Reduction Approach

SISs are part of a harm reduction approach to drug policy. Harm reduction aims to reduce the negative consequences of drug use, such as overdose deaths, HIV transmission, and crime. It does not condone drug use, but rather recognizes that it is a reality that must be addressed in a compassionate and evidence-based way.

International Perspective

SISs have been operating in other countries for decades, with positive results. There are currently over 200 SISs in operation worldwide. The opening of the SIS in Marseille marks a significant step forward in France's approach to drug policy and harm reduction.